ESG Supply Chain Due Diligence and Supplier Assessment

ESG Supply Chain Due Diligence and Supplier Assessment
Product Description

Positive Organizations builds the supplier ESG due diligence system that pharmaceutical procurement now requires, and that upstream regulation increasingly assumes.


Around 55 percent or more of pharmaceutical emissions and most human rights exposure sit with suppliers, and 69 percent of pharma leaders name limited value chain collaboration as their main barrier. Meanwhile CSDDD due diligence obligations phase in from 2028 and cascade contractually well before that.


We define ESG criteria for your supplier base, develop the assessment questionnaire or configure a screening tool, build a transparent scoring methodology with thresholds and escalation paths, and integrate the result into purchasing workflows, supplier qualification and audit programmes.


Available as a questionnaire-based or tool-based variant.

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
Specifications
  • Details
    Frameworks: CSDDD as amended by Omnibus I (transposition 26 July 2028, application from 26 July 2029), PSCI Principles for Responsible Supply Chain Management, EcoVadis supplier ratings, GRI 308 and GRI 414, SA8000, OECD Due Diligence Guidance, German LkSG and Swiss due diligence rules.


    Scope: supplier segmentation and risk mapping by category, country and spend; ESG criteria definition; questionnaire or tool development; scoring methodology, thresholds and red flags; onboarding and re-assessment cadence; corrective action and escalation process; integration into purchasing, qualification and audit workflows; buyer and supplier training.


    Application areas: pharma and biotech procurement, CDMO and CMO supplier management, API, excipient, packaging and logistics sourcing.
  • Selling Points
    Green Product; International Approvals/Standards; Quality Service; - Designed around pharma supplier realities, including single-source APIs
    - Aligned with PSCI so suppliers are not asked the same questions twice
    - Questionnaire-based or tool-based, matched to your supplier count
    - Scoring that procurement can defend to suppliers and auditors
    - Ready for CSDDD cascade requirements ahead of 2028
    - Feeds directly into your own EcoVadis Sustainable Procurement score
  • Supplied from
    Switzerland

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs

More Products from Positive Organizations (10)

  • Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Product Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Positive Organizations supports pharmaceutical companies that want to make a carbon neutrality claim and have it stand up to scrutiny.


    The rules changed. From 27 September 2026, Directive (EU) 2024/825 on empowering consumers for the green transition prohibits product claims such as carbon neutr...
  • Circular Economy, Resource Efficiency and Reffnet Consultancy

    Product Circular Economy, Resource Efficiency and Reffnet Consultancy

    Positive Organizations helps pharmaceutical manufacturers and packaging suppliers cut material and resource losses and build a credible circularity position.


    We map resource and material flows across your processes, visualise them with Sankey diagrams, benchmark efficiency against comparable ope...
  • Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Product Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Positive Organizations calculates your corporate carbon footprint, a greenhouse gas inventory covering Scope 1, Scope 2 and material Scope 3 categories, and then turns it into a reduction plan.


    At least 55 percent of pharmaceutical emissions sit in Scope 3, and manufacturing accounts for the maj...
  • EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Product EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Positive Organizations is an EcoVadis Accredited Consulting Partner and Approved Training Partner, and improves the ratings your pharmaceutical customers use to screen suppliers.


    EcoVadis scores you from 0 to 100 across Environment, Labor and Human Rights, Ethics and Sustainable Procurement, jud...
  • ESG Governance, Policies, Training, DEI and Leadership Coaching

    Product ESG Governance, Policies, Training, DEI and Leadership Coaching

    Positive Organizations puts the governance layer in place that ESG ratings, auditors and customers all look for, and then makes it live in the organisation.


    We draft the ESG documentation suite: whistleblower policy and reporting channel, code of conduct, code of ethics, human rights, anti-corru...
  • ESG Strategy, Materiality and Risk Assessment for Pharma

    Product ESG Strategy, Materiality and Risk Assessment for Pharma

    Positive Organizations builds the ESG strategy that sits underneath everything else, so your reporting, ratings and customer questionnaires draw on one coherent plan instead of ad hoc answers.


    We begin with an ESG maturity assessment and a peer benchmark against comparable pharmaceutical manufac...
  • ISO Certifications and B Corp Certification Support

    Product ISO Certifications and B Corp Certification Support

    Positive Organizations takes pharmaceutical companies and suppliers through management system certification and B Corp certification, from gap analysis to certificate.


    We support ISO 14001 environmental management, ISO 50001 energy management, ISO 45001 occupational health and safety, ISO 20121 ...
  • Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Product Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Positive Organizations conducts product and process life-cycle assessments to ISO 14040 and ISO 14044, quantifying the environmental impact of an API, a formulation, a device or a packaging system from raw material to end of life.


    In pharmaceutical manufacturing the impact is concentrated upstre...
  • PPWR Readiness Assessment for Pharma Packaging

    Product PPWR Readiness Assessment for Pharma Packaging

    Regulation (EU) 2025/40 (PPWR) has applied across the EU-27 since 12 August 2026. For pharma the exposure is uneven: primary packaging of medicinal products is exempt from the recyclability and recycled-content targets — but that exemption has to be documented, and secondary, transport and e-commerce packa...
  • Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Product Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Positive Organizations produces GRI-aligned and CSRD-compliant sustainability reports for pharmaceutical companies and their suppliers.


    Following the Omnibus I Directive (EU) 2026/470, mandatory ESRS reporting now applies to undertakings with more than 1,000 employees and over EUR 450 million tu...